New app could revolutionize how we measure sarcoma recovery

NCT ID NCT07227961

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a smartphone app can help track recovery in 800 sarcoma patients after surgery. Participants will fill out questionnaires and have their phone passively monitor steps, stairs, and other mobility data for up to a year. The goal is to see if this digital tool provides useful information that standard check-ups miss, potentially improving how doctors evaluate and support recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could provide doctors with better tools to measure and understand recovery after sarcoma surgery, leading to more personalized care.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve health. The app may have technical issues or not be user-friendly for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Foothills Medical Centre, Arthur J Child Comprehensive Cancer Centre, University of Calgary

    RECRUITING

    Calgary, Alberta, T2N 2T9, Canada

  • Mayo Clinic

    NOT_YET_RECRUITING

    Phoenix, Arizona, 85054, United States

  • Mayo Clinic

    NOT_YET_RECRUITING

    Rochester, Minnesota, 55905, United States

  • Mount Sinai Hospital, University of Toronto

    NOT_YET_RECRUITING

    Toronto, Ontario, M5G 1X5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.